Mutations in TMEM16F underlie Scott syndrome, characterized by defective exposure of PS on the outer membrane leaflet of platelets upon Ca2+-dependent activation and decreased levels of coagulation factors (9, 10). The gene discussed is ANO6; the disease is Scott syndrome.